OBLN Obalon Therapeutics Inc.

$-100%

49,153 Shares Traded
461,877 Average Volume (last 30 days)

as of February 23, 2018 EST IEX Real-Time Price

Short Pain Metrics

Approximate Amount of Money Shorts Have Made on the Day: $2.29 million
If Intiated on the First, Shorts Have Realized a Year to Date Return of:42.1%
If Intiated One Month Ago, Shorts Have Realized a Return of:20.23%
If Initiated Five Days ago, Shorts Have Realized a Return of:-5.34%
Peer Potential Short Squeezes Near Real Time Screener
*Please note the actual returns of shorts could be different as they started from different points

Daily Indicators

Daily Short Pain Indicator [i] - Always Use Fundamentals on EverythingNeutral
200 Day Moving Average Indicator Bearish
50 Day Moving Average Indicator Bearish
52 Week High/Low Indicator Neutral

Short Stats

Short Percent to Float 3.29%
Short Interest546.26 thousand
Float16.6 million
Short Ratio0.88
Market Cap$72.21 million
Market Maker ActivityDaily Short Volume

News

02-23-2018
EQUITY ALERT: Nationally Ranked Rosen Law Reminds Obalon Therapeutics, Inc. Investors of Important Deadline in Class Action- OBLN (Business Wire)
02-21-2018
OBALON INVESTOR ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 Investing In Obalon Therapeutics, Inc. To Contact The Firm (Business Wire)
02-21-2018
Your Daily Pharma Scoop: Portola Update, Wave Life Sciences To Collaborate With Takeda, AbbVie Reports Data For Egolix (SeekingAlpha)
02-20-2018
Obalon "all clear" after completing inquiry into possible improper FQ4 revenue recognition; shares up 6% (SeekingAlpha)
02-20-2018
Scott+Scott, Attorneys at Law, LLP Alerts Investors to the Filing of Securities Class Action Against Obalon Therapeutics, Inc. (Business Wire)
02-19-2018
Robbins Arroyo LLP: Obalon Therapeutics, Inc. (OBLN) Misled Shareholders According to a Recently Filed Class Action (Business Wire)
02-19-2018
Lifshitz & Miller LLP Announces Investigation of Advance Auto Parts, Inc., Ballard Power Systems, Inc., Connecture, Inc., Idera Pharmaceuticals, Inc., Impinj Inc., Obalon Therapeutics, Inc., and Super Micro Computer, Inc. (PR Newswire)
02-15-2018
EQUITY ALERT: Rosen Law Firm Announces Filing of Securities Class Action Lawsuit Against Obalon Therapeutics, Inc. - OBLN (Business Wire)
02-15-2018
OBALON INVESTOR ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 Investing In Obalon Therapeutics, Inc. To Contact The Firm (Business Wire)
02-15-2018
SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Notifies Investors of Class Action Against Obalon Therapeutics, Inc. (OBLN) & Lead Plaintiff Deadline: April 16, 2018 (PR Newswire)


Smart Money Sentiment

Institutional Ownership (Top 15 Funds) 60.3%

Earnings Stats

PE Ratio -2.08
Dividend Yield 0%
Peer EarningsEarnings Calendar

Technicals

200 Day Moving Average $8.43
50 Day Moving Average $5.82
52 Week High $13.18
52 Week Low $3.4



Data provided for free by IEX. Questions? Read the FAQ